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Abstract.  Most nonmuscle cells are known to main- 
tain a  relatively high concentration of unpolymerized 
actin. To determine how the polymerization of actin is 
regulated, exogenous nucleation sites, prepared by 
sonicating fluorescein phalloidin-labeled actin fila- 
ments, were microinjected into living Swiss 3T3 and 
NRK cells. The nucleation sites remained as a  cluster 
for over an hour after microinjection, and caused no 
detectable change in the phase morphology of the cell. 
As determined by immunofluorescence specific for en- 
dogenous actin and by staining cells with rhodamine 
phalloidin, the microinjection induced neither an ex- 
tensive polymerization of endogenous actin off the 
nucleation sites, nor changes in the distribution of ac- 
tin filaments. In addition, the extent of actin polymer- 
ization, as estimated by integrating the fluorescence in- 
tensities of bound rhodamine phalloidin, did not 
appear to be affected. To determine whether the nucle- 
ation sites remained active after microinjection, cells 
were first injected with nucleation sites and, following 
a 20-min incubation, microinjected with monomeric 
rhodamine-labeled actin. The rhodamine-labeled actin 
became extensively associated with the nucleation 
sites, suggesting that at least some of the nucleation 
activity was maintained, and that the endogenous actin 
behaved in a different manner from the exogenous ac- 
tin subunits. Similarly, when cells containing nuclea- 
tion sites were extracted and incubated with 
rhodamine-labeled actin, the rhodamine-labeled actin 
became associated with the nucleation sites in a 
cytochalasin-sensitive manner. These observations sug- 
gest that capping and inhibition of nucleation cannot 
account for the regulation of actin polymerization in 
living cells. However, the sequestration of monomers 
probably plays a crucial role. 
I 
N nonmuscle cells, close to 50% of total actin molecules 
appear to be present in the unpolymerized form (Bray 
and Thomas, 1976; Blikstad et al.,  1978). The amount 
of unpolymerized subunits decreases after the stimulation of 
polymorphonuclear leukocytes (Fechheimer and Zigmond, 
1983;  Rao and Varani,  1982),  Dictyosteliurn (Condeelis et 
al.,  1988),  and platelets (Carlsson et al.,  1979;  Fox and 
Philips, 1981), coincident with the appearance of new actin 
filaments. Thus, it is likely that these subunits may serve as 
building blocks and become assembled into filaments upon 
stimulation. 
However,  one  intriguing question  is  how  resting  cells 
maintain the relatively high concentration of unpolymerized 
actin. Based on in vitro measurements (Bonder et al., 1983), 
purified actin has a critical concentration of ,~0.3/~M under 
physiological ionic conditions. Assuming that the intracellu- 
lar  concentration of actin  is  200  #M,  one would expect 
>99% of actin to be in the filamentous form. The most likely 
way for maintaining a high concentration of unpolymerized 
actin is through interactions with various actin binding pro- 
teins.  Since actin polymerization involves  nucleation and 
subsequent addition of subunits to the nuclei or the ends of 
filaments, inhibition of polymerization can be achieved in 
two possible ways. First, monomeric actin can be maintained 
by binding to a protein that inhibits its polymerization activ- 
ity. Second, polymerization can be inhibited by a combina- 
tion of proteins that cap the ends of filaments and proteins 
that inhibit the formation of active nucleation sites.  Thus, 
even though actin subunits may be active, there are no avail- 
able sites for the assembly to take place. 
A wide variety of actin-binding proteins have been iden- 
tiffed in recent years (for reviews,  see Stossel  et al.,  1985; 
Pollard and Cooper, 1986). For example, gelsolin is a well- 
characterized protein that caps the barbed ends of actin fila- 
ments in a Ca-dependent manner (Yin and Stossel,  1979). 
Profilin can bind actin monomers and inhibit their polymer- 
ization (Carlsson et al.,  1977);  it may also inhibit the self- 
nucleation of actin (Pollard and Cooper,  1986).  Actobindin 
is also capable of sequestering actin monomers and inhibit- 
ing the formation of nucleation sites (Lambooy and Korn, 
1986, 1988). However, serious questions remain concerning 
the possible roles of these proteins in the regulation of actin 
polymerization in living cells. For example, a study by Lind 
et al. (1987) indicates that there may not be enough profilin 
in platelets to account for the maintenance of unpolymerized 
actin. In the same study, the extent of gelsolin-actin binding 
was found to increase, rather than decrease, after platelet ac- 
tivation, contrary to what one might expect if gelsolin were 
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since the actin binding activity of both gelsolin and profilin 
can be  inhibited by phosphatidylinositol-4,5-bisphosphate 
(Janmey and Stossel, 1987; Lassing and Lindberg, 1985), a 
common component of eukaryotic membranes, it is possible 
that these proteins might be at least partially inactive in rest- 
ing cells. 
In this paper, we attempt to delineate the mechanism ofac- 
tin regulation by microinjecting living cells with exogen- 
ous nucleation sites.  If the regulation of polymerization is 
achieved primarily by the capping of filaments in conjunc- 
tion with the inhibition of self nucleation, we might observe 
an increase in actin polymerization after the microinjection. 
Our results, however, indicate little or no stimulation of actin 
polymerization, even  though  the  nucleation  sites  remain 
capable of binding exogenous,  fluorescently labeled actin 
subunits. The results are thus more consistent with monomer 
sequestration being the primary mechanism of regulation. 
Materials and Methods 
Preparation of Nucleation Sites and Fluorescently 
Labeled Actins 
Muscle actin was purified from rabbit back and leg muscles after Spudich 
and Watt (1971). In some experiments, the actin was further purified by gel 
filtration chromatography in a Sephadex G-150 column (Sigma Chemical 
Co., St. Louis, MO), as described by MacLean-Fletcher and Pollard (1980). 
Nucleation sites were prepared by sonicating fluorescein phalloidin-labeled 
filaments of muscle actin. Briefly, G-actin was clarified at 25,000  rpm for 
20 min in a rotor (42.2 Ti rotor; Beckman Instruments, Inc., Palo Alto, CA), 
and polymerized in 2  mM Tris-acetate,  pH 6.95,  60 mM KCI,  1.4 mM 
MgCI2,  0.2  mM ATE 0.1  mM DTT.  Fluorescein phalloidin (Molecular 
Probes Inc., Eugene, OR) was dissolved in a microinjection buffer contain- 
ing 2  mM Tris-acetate, pH 6.95,  100 mM KCI,  2  mM MgCI2,  0.2 mM 
ATE 0.1  mM DTT.  After clarification, the phalloidin solution was mixed 
with actin at a phalloidin/actin molar ratio of 0.65:1.0. The mixture was then 
dialyzed for 2  h  against the microinjection buffer and sonicated for  15- 
30 s in a bath sonicator immediately before use. The nucleation sites were 
microinjected at a concentration of 13.3 #M actin. In some experiments, 
identical results were obtained with actin polymerized and microinjected in 
the presence of 2  mM MgCI2 and no KCI. 
N-(l-pyrenyl) iodoacelamide (Molecular Probes Inc.) labeled actin (py- 
rene actin) was prepared as described by Kouyama and Mihashi (1981) with 
minor modifications (Cooper et al.,  1983).  The dye-to-protein molar ratio 
was determined to be 0.8. Tetramethylrhodamine iodoacetamide (Molecular 
Probes Inc.) labeled actin (rhodamine actin) was prepared as described pre- 
viously (Wang,  1984).  The dye-to-protein molar ratio was estimated to be 
0.7. Rhodamine actin was microinjected in a buffer of 2 mM Tris-acetate, 
pH 6.95, 0.05 mM MgCI2, 0.2 mM ATE and 0.1 mM DTT at a concentra- 
tion of 4.0-5.0 mg/ml. 
Biochemical Assays 
The percentage of unpolymerized actin in normal rat kidney (NRK) I cells 
was determined with the DNase I assay at 25°C, essentially according to 
Blikstad  et al. (1978). To inhibit the depolymerization of F-actin after cell 
lysis, 8 #M phalloidin was included in the lysis buffer as described by Podol- 
ski and Steck (1988). Hydrolysis of  calf thymus DNA (Sigma Chemical Co.) 
was followed by the decrease in the fluorescence of ethidium bromide, 
which was added to the assay mixture at a concentration of 0.4 #g/ml (Laub 
et al.,  1981). Fluorescence measurements were performed with a spectro- 
fluorometer (LS-3; Perkin-Elmer Corp., Norwalk, CT),  at an excitation 
wavelength  of 520 nm and an emission wavelength of 602 rim.  Compared 
to the measurements of absorbance at 260 nm (Blikstad  et al.,  1978), this 
method offers a higher sensitivity and signal-to-noise ratio. 
The assay of the activity of nucleation sites in vitro was performed with 
pyrene actin, similar to that described by Gershman et al. (1984).  Pyrene 
actin was diluted with unlabeled actin to obtain a molar ratio of 1:20 and 
1. Abbreviations used in this paper:  NRK, normal rat kidney. 
a total G-actin concentration of 2.5 #M. At t =  0,  1 vol of a mixture of KCI 
and MgCI2, with or without 20 nM actin in the nucleation sites, was added 
to 8 vol of G-actin to obtain a final  KCI and MgCI2 concentrations of 55 
mM and 0.55  mM,  respectively. Increase in fluorescence was measured 
with an excitation wavelength of 365  nm and an emission wavelength of 
407 nm. 
Cell Culture, Microinjection, and Microscopy 
NRK epithelial cells (NRK-52E; American Type Culture Collection, Rock- 
ville, MD) were cultured in F12k  medium (Hazleton Research Products 
Inc.,  Lenexa, KS) supplemented with 5%  Nu-serum (Collaborative Re- 
search Inc., Bedford, MA), 50/~g/ml streptomycin and 50 U/ml penicillin, 
and were maintained at 36-37°C with 5% CO~2. In some experiments, sub- 
clones that showed a uniform phase morphology were used. Swiss 3T3 cells 
(American  Type  Culture  Collection)  were  cultured  in  DME  medium 
(Hazleton  Research Products Inc.)  supplemented with  10%  calf serum 
(Sigma, St.  Louis, MO), 50/~g/ml streptomycin and 50 U/ml penicillin. 
Cells were plated on microinjection dishes (McKenna and Wang,  1989) for 
12-24 h before microinjection. 
Microinjection was performed essentially according to Graessman et al. 
(1980).  The pressure was generated either with an empty syringe or with 
an electronic pressure regulation system developed in our laboratory.  The 
cells were maintained on a microscope stage enclosure as described previ- 
ously (McKenna and Wang,  1989). 
Fluorescence images were detected with an ISIT low-light-level  video 
camera (Dage-MTI, Michigan City, IN), coupled to a microscope (IM35 
or IM; Carl Zeiss, Inc., Thornwood, NY). The camera was operated below 
the level of saturation. All observations were made with either a 25x/NA 
0.8  Plan-Neofluar objective or a  100x/NA  1.3 Neofluar objective (Carl 
Zeiss Inc.). The software and hardware used for fluorescence image pro- 
cessing have been described previously (McKenna et al., 1985). A graphics 
tablet, in conjunction with programs developed in our laboratory, was used 
to obtain both averaged and integrated fluorescence intensities over specified 
areas. 
Fluorescent Staining of Cells 
Cells were rinsed with PHEM buffer (10 mM EGTA, 2 mM MgCi2, 60 
mM Pipes, 25 mM Hepes, pH 6.9; Schliwa and van Blerkom, 1981). NRK 
cells were extracted and fixed simultaneously with 0.5 % Triton X-100, 3.3 % 
formaldehyde (polysciences Inc., Warrington, PA) in PHEM buffer, pH 6.1, 
at 37°C for 5 min. 3T3 cells were fixed for 10 min with 3.2% formaldehyde 
in PHEM buffer, pH 6.1, at 37°C and then extracted for 5 min in an acetone 
bath chilled in dry ice. The latter procedure yielded a better retention of 
the nucleation sites. After three rinses with PHEM buffer, pH 6.9, cells were 
stained for 5 rain with rhndamine phalloidin dissolved in PHEM buffer, pH 
6.9,  following instructions from Molecular Probes Inc. 
Immunofluorescence staining was performed essentially as described by 
Amato et al.  (1983).  Antibody against the nonmuscle gamma actin was 
kindly provided by Dr. J. C. Bulinski (Columbia University, NY). This anti- 
body, referred to as the gamma peptide antibody, was prepared using a 
gamma-actin-specific synthetic peptide as the antigen and has been charac- 
terized in detail by Otey et al. (1986,  1988). 
Preparation of Cell Models 
Extracted cell models were prepared by replacing the culture medium with 
0.1% Triton X-100, 8 #M phalloidin (Boehringer Mannheim Biochemicals, 
Indianapolis, IN) in PHEM buffer, pH 6.1, and incubating at room tempera- 
ture for 2 min. The coverslip then was carefully rinsed with PHEM buffer, 
pH 6.9,  incubated for 5 min in a nucleation buffer (5 mM Hepes; pH 6.5, 
2 mM EGTA, 138 mM KCI, 1 mM ATP, with or without 0.5 #M cytochala- 
sin D) containing 8 #M phalloidin, and then incubated for 20 min with 20 
#g/ml rhodamine actin in the nucleation buffer.  Unbound actin was rinsed 
off with the nucleation buffer before observation. 
Results 
Characterization of Cells and Nucleation Sites 
Experiments were performed with NRK epithelial cells and 
Swiss 3T3 fibroblasts.  Under our culture conditions, most 
3T3  cells showed prominent stress fibers. Although stress 
fibers  were  detectable  in  NRK  cells  after  staining  with 
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closely spaced stress fibers, and thus a more uniform fluores- 
cence after staining with fluorescent phalloidin or antibod- 
ies. This greatly facilitated the comparison of fluorescence 
intensities at the nucleation sites and in the surrounding re- 
gion.  In addition,  NRK cells were much more uniform in 
shape and size. For these reasons, NRK cells were used in 
most experiments,  although  similar results  were obtained 
with 3T3 cells. We have used the DNase I assay to measure 
the  percentage of unpolymerized actin in  NRK cells.  The 
value, 50-60%,  is very similar to those reported for other 
cultured cells (Blikstad et al.,  1978). 
Nucleation sites were prepared by sonicating muscle actin 
filaments that had been labeled with fluorescein phalloidin. 
Fluorescein phalloidin served both to stabilize the nucleation 
sites, and to label the nucleation sites for detection.  As de- 
scribed by Yanagida et al. (1984) and by Kron and Spudich 
(1986),  individual  actin filaments labeled with fluorescein 
phalloidin can be directly observed under a fluorescence mi- 
croscope (Fig.  1). The sonicated fragments had an apparent 
length of 0.9  +  0.8 #m (n  =  151). 
The ability of the actin filament fragments to nucleate actin 
assembly in vitro was confirmed with pyrene actin (Gersh- 
man et al.,  1984).  A lag period of 1-2 min, detected in the 
absence of nucleation sites, was completely abolished by the 
addition of nuclei containing 2.2  nM actin (Fig.  2). 
Failure of the Microinjected  Nucleation Sites to 
Stimulate Extensive Actin Polymerization 
Nucleation  sites  were microinjected  into  NRK and  Swiss 
3T3 cells to determine whether they can induce polymeriza- 
tion of endogenous actin subunits.  The injection caused no 
detectable change in the cell as determined by phase optics. 
After a 20-min incubation, injected cells were processed for 
indirect immunofluorescence to reveal the distribution of ac- 
tin. We have used a primary antibody that reacts only with 
endogenous nonmuscle actin (Otey et al.,  1986), to exclude 
the staining of microinjected nucleation  sites.  Rhodamine- 
labeled secondary antibodies were used to allow distinction 
from the fluorescein-labeled nucleation sites. 
The distribution of actin in injected cells appeared indis- 
tinguishable from that in uninjected cells. Furthermore, little 
or  no  increase  in  local  actin  concentration  was  observed 
around the microinjected nucleation sites, as shown in Fig. 
Figure 1. Fluorescence microscopy of actin nucleation sites. Fluo- 
rescein phalloidin-labeled actin filaments were sonicated for 20 s 
and directly observed with a fluorescence microscope at a concen- 
tration of 27 nM. Each bright segment or spot probably represents 
a single fragment.  Bar, 5 #m. 
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Figure 2. Nucleation activity of the fragments of actin filaments as 
determined with pyrene actin. At t =  0, polymerization was initi- 
ated by the addition of KCI and MgCI2, with or without the nucle- 
ation sites, to 2.5 #M G-actin containing 5% pyrene actin.  Poly- 
merization was manifested as an increase in fluorescence intensity. 
In the absence of nucleation sites, there was a lag period of t-2 min 
(o). In the presence of nucleation sites containing 2.2 nM actin, 
the  lag period  was abolished  and the  polymerization  proceeded 
much more quickly (e). 
3. The averaged signal at the nucleation sites was very close 
to that in the surrounding region (ratio =  1.04  +  0.09,  n  = 
17). Similar results were obtained with nucleation sites pre- 
pared from column-purified actin (ratio =  1.11 +  0.12, n  = 
13), indicating that the trace amount of capping factors in the 
conventional preparation of actin is not responsible for the 
lack of stimulated polymerization. 
A second way to examine the effect of the nucleation sites 
was to measure the total amount of filamentous actin in in- 
jected cells. To this end, one member of a pair of NRK sister 
cells was microinjected with fluorescein-labeled nucleation 
sites. After 20-min incubation, both cells were stained with 
rhodamine phalloidin (Fig. 4). Because of the specific bind- 
ing of phalloidin with F-actin, the integrated fluorescence in- 
tensity over a cell should be proportional to the total amount 
of actin filaments. The values from paired sister cells were 
within2% of each other (ratio =  1.005 +  0.23, n =  15), sug- 
gesting that there was no significant increase in the extent of 
actin polymerization after the microinjection of nucleation 
sites. Similar results were obtained with nucleation sites pre- 
pared from column-purified actin  (ratio  =  1.004  +  0.15, 
n  =  11). 
Interactions between Microinjected Nucleation Sites 
and Exogenous Actin Subunits 
We have performed double microinjection  experiments to 
determine whether the nucleation sites have maintained the 
ability to interact with exogenous actin subunits.  NRK and 
Swiss 3T3 cells were first microinjected with the nucleation 
sites, and then incubated for 20 rain before the second injec- 
tion with monomeric rhodamine actin. After further incuba- 
tion for 20 min, cells were fixed and extracted and the rhoda- 
mine  fluorescence  examined.  As  shown  in  Fig.  5,  the 
rhodamine actin clearly became associated with the nuclea- 
tion sites. For NRK cells the averaged signal at the nuclea- 
tion  sites  was  80%  higher  than  that  in  the  surrounding 
cytoplasm (ratio =  1.80 +  0.43, n  =  16), indicating that the 
nucleation  sites  had  maintained  the  ability  to  bind  actin 
subunits.  These results were independent of the site of the 
second microinjection relative to that of the first injection. 
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plasmic actin with microinjected  nu- 
cleation sites. An NRK (a and b) or 
Swiss 3T3 (c and d) cell was micro- 
injected  with fluorescein  phalloidin- 
labeled  nucleation  sites,  incubated 
for 20 min, and then processed for 
indirect immunofluorescence  using a 
primary antibody specific for the en- 
dogenous  actin  and  a  rhodamine- 
labeled secondary antibody. Fluores- 
cein fluorescence  shows a cluster of 
nucleation  sites  (b and d).  Rhoda- 
mine fluorescence  indicates  that en- 
dogenous actin  fails  to concentrate 
around the nucleation  sites (a and c; 
arrows).  Bar,  10 #m. 
Control experiments were performed by using rhodamine- 
labeled ovalbumin in the second microinjection.  Before ex- 
traction and fixation,  there was no detectable concentration 
of ovalbumin at the nucleation  sites.  After extraction,  the 
ovalbumin became dissociated from the cell beyond the level 
of detection. These results ruled out nonspecific associations 
through the rhodamine group as a  binding mechanism.  As 
a second control, we used buffer alone in the second microin- 
jection, and then processed the cell for actin immunofluores- 
cence. No concentration of endogenous actin at the nuclea- 
tion  sites  was  detected,  indicating  that  the  association  of 
exogenous actin  was not caused by perturbations  from the 
second microinjection. 
In Fig.  6,  rhodamine actin was microinjected  into NRK 
cells 1 h before the microinjection of nucleation sites. In this 
case, little or no association with the nucleation sites was de- 
tected.  The results  were  similar  to that obtained  by single 
microinjection and immunofluorescence (Fig. 3), suggesting 
that cells may be able to regulate the exogenous actin follow- 
ing a  period of incubation. 
To characterize further the association of exogenous actin 
with the nucleation sites, extracted, phalloidin-stabilized cell 
Figure 4.  Similar  distribution  of actin filaments  in injected  and uninjected  sister cells.  One of a pair of sister  NRK cells  in a subclone 
was microinjected  with fluorescein-labeled  nucleation  sites. The cells were incubated  for 20 rain,  and then stained with rhodamine phal- 
loidin. The distribution  of rhodamine fluorescence  was similar for injected (b) and uninjected  (a) cells. No concentration of actin filaments 
was detected  near the cluster of nucleation  sites (arrow).  The nucleation  sites themselves  were labeled  poorly with rhodamine phalloidin 
since they were already heavily  labeled  with  fluorescein  phalloidin.  Bar,  10 t~m. 
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units with microinjected nucleation sites. An 
NRK (a and b) or Swiss 3T3 (c and d) cell was 
first microinjected with fluorescein-labeled nu- 
cleation sites. After incubation for 20 min, the 
cells were microinjected with rhodamine actin 
and subjected to extraction and fixation. Fluo- 
rescein images show the cluster of nucleation 
sites (b and d). Rhodamine fluorescence dem- 
onstrates an extensive association of injected 
actin with the nucleation sites (a  and  c;  ar- 
rows). Bar, 10/~m. 
models were prepared after the NRK cells had been microin- 
jected  with  nucleation  sites.  The cell  model was then  in- 
cubated with rhodamine actin under a condition that was un- 
favorable  for  self-nucleation  but  allowed  elongation.  As 
shown in Fig. 7 a, the rhodamine actin became associated 
with both the nucleation sites and the cytoskeleton, with the 
nucleation sites  being the most prominent structure.  When 
0.5 ~tM cytochalasin D was included during the incubation, 
the labeling of both the cytoskeleton and the nucleation sites 
was  significantly reduced (Fig.  7  b),  even though the nu- 
cleation sites  remained intact as detected with fluorescein 
fluorescence. 
Discussion 
Since  actin  polymerization involves  two  discrete  compo- 
nents, actin monomers and nucleation sites or filament ends, 
the reaction may be inhibited by blocking the activity of ei- 
ther component.  Thus,  two possible  mechanisms may be 
used by the cell to maintain a high level of unpolymerized 
actin: blocking the activity of monomers, or capping the fila- 
ments and inhibiting the formation of nucleation sites.  The 
two mechanisms may be distinguished by determining which 
component remains active in the cell. 
We have microinjected functional nucleation sites,  which 
consisted of fragments of fluorescein phalloidin-labeled ac- 
tin filaments,  into living cells to test whether they can induce 
polymerization of the endogenous actin subunits.  Based on 
an average length of 0.9/~m or ~300 subunits and an actin 
concentration of 0.6 mg/ml, one can estimate that 100-1,000 
nucleation sites were delivered per 1 ×  10  -~4 liter.  Further- 
more, assuming that the microinjected volume corresponded 
Figure 6.  Lack of association of exogenous actin with nucleation sites following an extended period of incubation. An NRK cell was first 
microinjected with rhodamine actin, incubated for 1 h, and then microinjected with fluorescein-labeled nucleation sites. After further incu- 
bation for 20 min, the cell was extracted and fixed. Fluorescein fluorescence shows the cluster of nucleation sites (b). Rhodamine actin 
fails to show a detectable concentration at the nucleation sites (a, arrow).  Bar, 10/~m. 
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rhodamine actin with nucleation sites and cyto- 
skeletons. NRK cells were microinjected with 
fluorescein-labeled nucleation sites. After in- 
cubation for 20 min, the cells were extracted 
with 0.1% Triton X-100 and  incubated with 
rhodamine actin under a condition unfavorable 
for self-nucleation. In the absence of  cytochala- 
sin D (a), there was an extensive association of 
rhodamine actin with both the nucleation sites 
(arrow) and the cytoskeleton. In the presence of 
0.5 ~M  cytochalasin D (b),  the associations 
with both the nucleation sites (arrow) and the 
cytoskeleton were severely inhibited. Images in 
the two panels were recorded and printed under 
identical conditions. Bar, 10 #m. 
to 5%  cell volume,  the amount of actin microinjected as 
nucleation sites should correspond to <0.5 % of the endoge- 
nous actin. 
Based on staining with fluorescent phalloidin and on in- 
direct immunofluorescence with antibodies specific for en- 
dogenous actin (Fig. 3), the nucleation sites induced no de- 
tectable change  in  the distribution of actin.  Furthermore, 
little or no endogenous actin became associated  with  the 
nucleation sites.  One possibility is that new actin filaments 
did assemble at the nucleation sites,  but subsequently dis- 
sociated and moved to other regions of the cell. However, 
when injected and uninjected sister cells were stained with 
rhodamine  phalloidin,  similar  total  intensities  were  ob- 
tained, indicating that there was no detectable increase in the 
total amount of actin filaments after the microinjection of 
nucleation sites. 
Therefore, either endogenous actin subunits were incapa- 
ble of polymerizing onto the nucleation sites, or the nuclea- 
tion sites became inhibited after microinjection. This ques- 
tion was examined both by microinjecting rhodamine actin 
into cells that had previously been microinjected with nucle- 
ation sites, and by incubating nucleation sites in cell models 
with rhodamine-labeled actin subunits. In both cases, exoge- 
nous actin became extensively associated with the nucleation 
sites,  indicating  that  the  nucleation  sites  have maintained 
their activities.  Control experiments indicated that the as- 
sociation  was  not  because  of either  nonspecific  binding 
through  the  rhodamine  group  or  perturbations  from  the 
microinjection. In addition, the sensitivity of the association 
of rhodamine actin with nucleation sites to cytochalasin D 
suggested that at least part of the association represented po- 
lymerization at the barbed ends. 
Based on these observations, we may conclude that endog- 
enous actin subunits, as compared to exogenous purified ac- 
tin,  are  much  less  capable  of interacting with  nucleation 
sites.  In  the  experiment  involving  the  microinjection of 
rhodamine actin (Fig. 5), assuming that 5 % cell volume of 
rhodamine actin at 100 #M was microinjected, the cytoplasm 
should contain approximately 5 p.M rhodamine actin, which 
showed  extensive incorporation  into  the  nucleation  sites. 
Thus, the concentration of endogenous "active" actin is prob- 
ably much lower than 5 #M, or '~5 % of the unpolymerized 
actin molecules. 
The simplest explanation for this observation is that mono- 
mer sequestration proteins play a major role in regulating ac- 
tin polymerization. Although the  regulation of nucleation 
and the capping of filament ends may also be involved in con- 
trolling the rate or location of actin polymerization after cell 
activation, it is unlikely to be responsible for maintaining the 
high concentration of unpolymerized  actin molecules in rest- 
ing cells. This conclusion is consistent with previous experi- 
ments involving the microinjection of fluorescently-labeled 
actin  into cultured cells (Glacy,  1983).  Incorporation into 
microfilament-rich  structures,  including  lamellipodia  and 
stress fibers, was detected within 5 min of microinjection, in- 
dicating that the ends of endogenous actin filaments in these 
structures are not stably capped. 
The protein(s) actually responsible for the sequestration of 
actin monomers remains to be identified. The candidate must 
be relatively abundant to inhibit a high concentration of actin 
monomers (close to 100/~M), and should respond to certain 
second messengers to allow actin polymerization in response 
to stimuli. Profilin represents the best characterized mono- 
mer sequestration protein, but its affinity for actin and its in- 
tracellular concentration may not be high enough to account 
for the extent of inhibition (Pollard and Cooper, 1986;  Lind 
et al.,  1987). Actin depolymerizing factor from chick brain 
(Bamburg et al.,  1980), and similar proteins found in Acan- 
thamoeba  and  in  starfish  oocyte  (Cooper  et  al.,  1986; 
Mabuchi,  1983)  are attractive alternatives, but the amount 
of this protein again appears too low to account for the extent 
of inhibition of polymerization (Cooper et al.,  1986; Koffer 
et al.,  1988). Actobindin also binds actin monomers and is 
present at a relatively high concentration in Acanthamoeba. 
However, the affinity of this protein for actin monomers ap- 
pears low (Lambooy and Korn,  1986,  1988).  A  definitive 
identification of the monomer sequestration protein and its 
control mechanism represents the crucial next step in our un- 
derstanding of the regulation of actin polymerization in liv- 
ing cells. 
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